Bushra Osmani is an Endocrinology/Metabolic physician. OpenAlex indexes 11 publications with 462 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
854 W James M Campbell Blvd Ste 100
Columbia, TN 384014792
Telephone
931-490-7050Provider last certified this registry record 5 May 2023.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20256 payments
- CeQur CorporationProgram year20251 payment
- Ascendis Pharma Endocrinology IncProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
78.5%Insulin Analog28.9%Toujeo Max Solostar29%Tresiba Flextouch U-20010%Novolog Flexpen10%Tresiba Flextouch U-1007%Humalog Kwikpen U-1006%Insulin Lispro Kwikpen U-1006%Humalog5%Toujeo Solostar5%Lantus Solostar5%Novolog5%Insulin Lispro4%Humalog Junior Kwikpen3%Levemir Flexpen2%Humalog Kwikpen U-2002%Soliqua 100-332%Part D<11 patientsGLP-1 receptor agonist27.9%Mounjaro56%Ozempic34%Rybelsus5%Trulicity5%Part D<11 patients+ 5 more classes in this area
Hormonal (systemic)
16.4%l-Thyroxine12.8%Levothyroxine Sodium79%Synthroid12%Unithroid9%Part D<11 patientsThyroid Hormone Synthesis Inhibitor2.4%Methimazole100%Part D≥21 patients+ 2 more classes in this area
Sensory organs
2.6%Corticosteroid2.6%Hydrocortisone45%Dexamethasone29%Solu-Cortef26%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”